Minimally invasive approaches for gastric cancer—Korean experience

Yang, Han‐Kwang; Suh, BS Yun-Suhk; Lee, Hyuk-Joon

doi:10.1002/jso.23179

Cited by 33 publications

(20 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There have been reports of short-term outcomes with morbidity rates of 11.3-15.9% and mortality rates of 0.8-2.2%, which are comparable to those of open surgery [2]. …”

Section: Laparoscopic Gastrectomy For Advanced Cancermentioning

confidence: 99%

“…As the surgical quality may become one of the most important issues in this clinical trial, surgeons are required to be standardized and qualified by participating in a surgical quality control trial, entitled ‘KLASS-02-QC: Standardization of D2 Lymphadenectomy and Surgical Quality Control for KLASS-02 Trial' (NCT01283893). Each applicant should submit three unedited videos each for LADG and ODG, respectively, which are to be evaluated by independent reviewers [2]. As a result, only certified surgeons can join KLASS-02-RCT.…”

Section: Laparoscopic Gastrectomy For Advanced Cancermentioning

confidence: 99%

“…In Korea, for example, the number of laparoscopic surgeries for gastric cancer increased from 740 in 2004 to 3,783 in 2009, rising from 6.6% of all gastric cancer surgeries to 25.8%, respectively [2]. The cumulative number of laparoscopic gastric cancer surgeries from 1995 to 2009 was estimated to be 14,731 in Korea [3].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Laparoscopic Gastrectomy for Gastric Cancer

Lee

Yang²

2013

Dig Surg

Self Cite

View full text Add to dashboard Cite

Laparoscopic gastrectomy for gastric cancer is rapidly becoming popular because of the technical developments and the accumulated data of laparoscopic surgery in gastric cancer patients. The aim of this review is to present the current body of evidence and to highlight controversial issues of laparoscopic gastrectomy for gastric cancer. Laparoscopic distal gastrectomy (LDG) provides better or comparable outcomes compared to conventional open distal gastrectomy (ODG) in terms of short-term results. The long-term survival of LDG is expected to be comparable to that of ODG in early-stage gastric cancer, and an ongoing Korean multicenter randomized controlled trial (KLASS-01) will provide more clear evidence. Laparoscopic total gastrectomy is still selectively performed compared to LDG, and there is still debate on the safety of the laparoscopic esophagojejunostomy technique. Laparoscopic pylorus-preserving gastrectomy seems to be preferred for early gastric cancer in the middle third of the stomach in terms of functional advantages and comparable oncologic outcome. Evidence for LDG for advanced gastric cancer is still insufficient and the issue of lack of generalization still remains, even after ongoing multicenter randomized controlled trials have revealed clinical evidence. Laparoscopic sentinel node navigation surgery is still experimental and the surgical procedure has yet to be standardized. Robotic gastrectomy is feasible for early gastric cancer in terms of similar outcome, but is much more expensive in comparison to laparoscopic surgery. Its benefit over the conventional laparoscopic gastrectomy has not yet been proven.

show abstract

“…There have been reports of short-term outcomes with morbidity rates of 11.3-15.9% and mortality rates of 0.8-2.2%, which are comparable to those of open surgery [2]. …”

Section: Laparoscopic Gastrectomy For Advanced Cancermentioning

confidence: 99%

Section: Laparoscopic Gastrectomy For Advanced Cancermentioning

confidence: 99%

See 1 more Smart Citation

Laparoscopic Gastrectomy for Gastric Cancer

Lee

Yang²

2013

Dig Surg

Self Cite

View full text Add to dashboard Cite

show abstract

“…Laparoscopic gastrectomy has been known to have several advantages, including less postoperative pain, better cosmesis, less inflammatory reaction, rapid recovery of bowel function, and fast recovery compared to conventional open surgery (1). For early gastric cancer, laparoscopic gastrectomy and lymph node dissection is considered safe and comparable procedure in terms of postoperative outcome even in large scale randomized clinical trial, and also expected to show promising long-term survival outcome (2)(3)(4).…”

Section: Introduction For Single-incision Laparoscopic Surgery (Sils)mentioning

confidence: 99%

Single incision gastrectomy for gastric cancer

Suh

Lee

Yang

2016

Transl. Gastroenterol. Hepatol.

Self Cite

View full text Add to dashboard Cite

Based on rapid development of laparoscopic techniques and instruments, single-incision laparoscopic surgery (SILS) is expected to be the next step of "more" minimally invasive surgery. A few institutions gradually started to report their experience of single incision gastrectomy (SIG) for gastric cancer, but it is still difficult to accept that SIG can be performed as a popular procedure because of its technical difficulty. For wide adoption of SIG, the simplicity, safety and reproducibility of not only lymph node dissection but also reconstruction should be evaluated compared to a conventional procedure. With a thorough understanding of unique characteristics of SILS, single incision distal gastrectomy (SIDG) for early gastric cancer performed by laparoscopic surgeons with advanced technique is expected to have promising potential about excellent cosmesis, comparable morbidity and mortality in carefully selected patients. For appropriate adoption and steady progress of this state-of-the art surgery, scientific evaluation with healthy critics is necessary with new generation of SILS instrument platform.

show abstract

“…Robot-assisted surgery is performed in many hospitals, especially for early stages of cancers. [1][2][3] However, reports on robot assisted combined operations are very limited. We report the first successful concurrent robotassisted distal gastrectomy and partial nephrectomy in a patient with synchronous early gastric cancer and renal cell carcinoma.…”

Section: Introductionmentioning

confidence: 99%

Concurrent Robot-Assisted Distal Gastrectomy and Partial Nephrectomy for Synchronous Early Gastric Cancer and Renal Cell Carcinoma: An Initial Experience

Kim

Seo

et al. 2014

J Gastric Cancer

View full text Add to dashboard Cite

We report our experience of a concurrent robot assisted distal gastrectomy and partial nephrectomy for synchronous early gastric cancer and renal cell carcinoma. A 55-year-old female patient was diagnosed with early gastric cancer on screening endoscopy. Abdominal computed tomography showed an incidental right renal cell carcinoma. Robot assisted distal gastrectomy was performed, followed by partial nephrectomy. The final pathological examination showed signet ring cell carcinoma within the lamina propria and renal cell carcinoma with negative resection margins. The patient showed no evidence of recurrence at 6-months. A robot-assisted combined operation could be a treatment option for early stages of synchronous malignancies.

show abstract

Minimally invasive approaches for gastric cancer—Korean experience

Cited by 33 publications

References 68 publications

Laparoscopic Gastrectomy for Gastric Cancer

Laparoscopic Gastrectomy for Gastric Cancer

Single incision gastrectomy for gastric cancer

Concurrent Robot-Assisted Distal Gastrectomy and Partial Nephrectomy for Synchronous Early Gastric Cancer and Renal Cell Carcinoma: An Initial Experience

Contact Info

Product

Resources

About